Cargando…

Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability

The potential of poly (lactic-co-glycolic acid) nanoparticles (PLGA NPs) to overcome the intestinal barrier that limits oral liraglutide delivery was evaluated. Liraglutide-loaded PLGA NPs were prepared by the double emulsion solvent evaporation method. In vitro release kinetics and enzymatic degrad...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Ruba, Bocsik, Alexandra, Katona, Gábor, Gróf, Ilona, Deli, Mária A., Csóka, Ildikó
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920980/
https://www.ncbi.nlm.nih.gov/pubmed/31726699
http://dx.doi.org/10.3390/pharmaceutics11110599
_version_ 1783481058117812224
author Ismail, Ruba
Bocsik, Alexandra
Katona, Gábor
Gróf, Ilona
Deli, Mária A.
Csóka, Ildikó
author_facet Ismail, Ruba
Bocsik, Alexandra
Katona, Gábor
Gróf, Ilona
Deli, Mária A.
Csóka, Ildikó
author_sort Ismail, Ruba
collection PubMed
description The potential of poly (lactic-co-glycolic acid) nanoparticles (PLGA NPs) to overcome the intestinal barrier that limits oral liraglutide delivery was evaluated. Liraglutide-loaded PLGA NPs were prepared by the double emulsion solvent evaporation method. In vitro release kinetics and enzymatic degradation studies were conducted, mimicking the gastrointestinal environment. The permeability of liraglutide solution, liraglutide-loaded PLGA NPs, and liraglutide in the presence of the absorption enhancer PN159 peptide was tested on the Caco-2 cell model. Liraglutide release from PLGA NPs showed a biphasic release pattern with a burst effect of less than 15%. The PLGA nanosystem protected the encapsulated liraglutide from the conditions simulating the gastric environment. The permeability of liraglutide encapsulated in PLGA NPs was 1.5-fold higher (24 × 10(−6) cm/s) across Caco-2 cells as compared to liraglutide solution. PLGA NPs were as effective at elevating liraglutide penetration as the tight junction-opening PN159 peptide. No morphological changes were seen in the intercellular junctions of Caco-2 cells after treatment with liraglutide-PLGA NPs, confirming the lack of a paracellular component in the transport mechanism. PLGA NPs, by protecting liraglutide from enzyme degradation and enhancing its permeability across intestinal epithelium, hold great potential as carriers for oral GLP-1 analog delivery.
format Online
Article
Text
id pubmed-6920980
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69209802019-12-24 Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability Ismail, Ruba Bocsik, Alexandra Katona, Gábor Gróf, Ilona Deli, Mária A. Csóka, Ildikó Pharmaceutics Article The potential of poly (lactic-co-glycolic acid) nanoparticles (PLGA NPs) to overcome the intestinal barrier that limits oral liraglutide delivery was evaluated. Liraglutide-loaded PLGA NPs were prepared by the double emulsion solvent evaporation method. In vitro release kinetics and enzymatic degradation studies were conducted, mimicking the gastrointestinal environment. The permeability of liraglutide solution, liraglutide-loaded PLGA NPs, and liraglutide in the presence of the absorption enhancer PN159 peptide was tested on the Caco-2 cell model. Liraglutide release from PLGA NPs showed a biphasic release pattern with a burst effect of less than 15%. The PLGA nanosystem protected the encapsulated liraglutide from the conditions simulating the gastric environment. The permeability of liraglutide encapsulated in PLGA NPs was 1.5-fold higher (24 × 10(−6) cm/s) across Caco-2 cells as compared to liraglutide solution. PLGA NPs were as effective at elevating liraglutide penetration as the tight junction-opening PN159 peptide. No morphological changes were seen in the intercellular junctions of Caco-2 cells after treatment with liraglutide-PLGA NPs, confirming the lack of a paracellular component in the transport mechanism. PLGA NPs, by protecting liraglutide from enzyme degradation and enhancing its permeability across intestinal epithelium, hold great potential as carriers for oral GLP-1 analog delivery. MDPI 2019-11-12 /pmc/articles/PMC6920980/ /pubmed/31726699 http://dx.doi.org/10.3390/pharmaceutics11110599 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ismail, Ruba
Bocsik, Alexandra
Katona, Gábor
Gróf, Ilona
Deli, Mária A.
Csóka, Ildikó
Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability
title Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability
title_full Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability
title_fullStr Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability
title_full_unstemmed Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability
title_short Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability
title_sort encapsulation in polymeric nanoparticles enhances the enzymatic stability and the permeability of the glp-1 analog, liraglutide, across a culture model of intestinal permeability
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920980/
https://www.ncbi.nlm.nih.gov/pubmed/31726699
http://dx.doi.org/10.3390/pharmaceutics11110599
work_keys_str_mv AT ismailruba encapsulationinpolymericnanoparticlesenhancestheenzymaticstabilityandthepermeabilityoftheglp1analogliraglutideacrossaculturemodelofintestinalpermeability
AT bocsikalexandra encapsulationinpolymericnanoparticlesenhancestheenzymaticstabilityandthepermeabilityoftheglp1analogliraglutideacrossaculturemodelofintestinalpermeability
AT katonagabor encapsulationinpolymericnanoparticlesenhancestheenzymaticstabilityandthepermeabilityoftheglp1analogliraglutideacrossaculturemodelofintestinalpermeability
AT grofilona encapsulationinpolymericnanoparticlesenhancestheenzymaticstabilityandthepermeabilityoftheglp1analogliraglutideacrossaculturemodelofintestinalpermeability
AT delimariaa encapsulationinpolymericnanoparticlesenhancestheenzymaticstabilityandthepermeabilityoftheglp1analogliraglutideacrossaculturemodelofintestinalpermeability
AT csokaildiko encapsulationinpolymericnanoparticlesenhancestheenzymaticstabilityandthepermeabilityoftheglp1analogliraglutideacrossaculturemodelofintestinalpermeability